Non-infectious tuberculous pleurisy usually requires treatment for about 6 months, which also needs to be adjusted appropriately according to the effect of treatment and review results. Tuberculous pleurisy is an inflammatory reaction triggered by Mycobacterium tuberculosis infection of the pleura, which usually manifests symptoms such as chest tightness, chest pain, dyspnea, low-grade fever and night sweats. The treatment of tuberculous pleurisy includes anti-tuberculosis treatment and general treatment. Anti-tuberculosis treatment cycle is generally longer, the standard anti-tuberculosis treatment course for primary tuberculous pleurisy is 6 months, including intensive treatment (oral isoniazid, pyrazinamide, ethambutol, rifampicin) for 2 months and consolidation treatment (isoniazid, rifampicin) for 4 months. However, the anti-tuberculosis treatment regimen is not set in stone, and adjustments need to be made during this period based on the results of the review, the response to the medication, etc. If multidrug-resistant Mycobacterium tuberculosis is present, the treatment cycle will be extended. General treatment mainly includes rest, maintaining adequate nutrition, and treatment of pleural effusion. The treatment of tuberculous pleurisy goes well, and the drugs can be stopped after 6 months of anti-tuberculosis treatment, multiple reexaminations of tuberculosis bacilli turn negative, and clinical symptoms improve.